The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling
Abstract Metastasis is the major cause of prostate cancer (PCa)‐related mortality. Epithelial‐mesenchymal transition (EMT) is a vital characteristic feature that empowers cancer cells to adapt and survive at the beginning of metastasis. Therefore, it is essential to identify the regulatory mechanism...
Main Authors: | Zean Li, Qiong Wang, Shirong Peng, Kai Yao, Junxiu Chen, Yiran Tao, Ze Gao, Fen Wang, Hui Li, Wenli Cai, Yiming Lai, Kaiwen Li, Xu Chen, Hai Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.191 |
Similar Items
-
DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation
by: Jian SHEN, et al.
Published: (2021-07-01) -
Knockdown of DEPDC1B inhibits the development of glioblastoma
by: Xu Chen, et al.
Published: (2020-07-01) -
Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway
by: Yanli Li, et al.
Published: (2021-06-01) -
Active RAC1 Promotes Tumorigenic Phenotypes and Therapy Resistance in Solid Tumors
by: Pradip De, et al.
Published: (2020-06-01) -
DEP Domain-Containing Protein 1B (DEPDC1B) Promotes Migration and Invasion in Pancreatic Cancer Through the Rac1/PAK1-LIMK1-Cofilin1 Signaling Pathway
by: Zhang S, et al.
Published: (2020-02-01)